Financial Summary for the Fiscal Year Ending December 2025 [Japan GAAP] (Consolidated)

Business Overview

The consolidated results for the fiscal year ending December 2025 showed net sales of 6,539,159 thousand yen (10.7% YoY increase), operating income of 349,464 thousand yen (a significant increase from operating income of 3,765 thousand yen in the previous period), ordinary income of 360,721 thousand yen, and net income attributable to owners of parent of 280,242 thousand yen (recovered from a net loss of 791,169 thousand yen in the previous period). Net sales increased across all service segments including Data Network Services, Data Utilization Services, and Other Services. In particular, Data Utilization Services achieved record-high sales due to an increase in sales personnel. The patient count in the large-scale medical database expanded to 55.02 million, an increase of 4.73 million compared to the same month the previous year.

Financial Position and Cash Flows

Total assets slightly increased to 4,778,436 thousand yen compared to the previous period, while net assets slightly decreased to 3,111,239 thousand yen. The equity ratio remained stable at 64.4%. Cash flow from operating activities was positive at 782,205 thousand yen, resulting in an increase in cash and cash equivalents at the end of the period to 1,713,216 thousand yen. Cash outflows from investing activities amounted to 96,927 thousand yen, financing activities outflows were 319,328 thousand yen, and dividend payments totaled 245,897 thousand yen.

Outlook

Due to the tender offer disclosed by Nihon Life Insurance Company on December 15, 2025, the Company’s shares are scheduled to be delisted, and consolidated earnings forecasts for the fiscal year ending December 2026 are not provided. The tender offer has been successful, and the tender offeror is expected to become the largest shareholder. Accordingly, the Company intends to undergo necessary procedures for delisting.